ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 644621 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 644621; 2) Community: the network communities that were significantly associated with the response to NSC 644621; 3) Molecule: the relationships between components within communities and NSC 644621; 4) MDR: the compounds that were significantly associated with the NSC 644621.

NSC Compound Enrichment Correlation
NSC 630703 Acridomide 0.0273093708703115 -0.057822042
NSC 631911 9H-[1,2,4]-Triazolo[5,1-b][1,3]benzothiazin-9-one, 2-(chloromethyl)- 0.0273093708703115 0.027258801
NSC 646379 Null 0.0273093708703115 0.131753
NSC 670964 Null 0.0273093708703115 0.36973247
NSC 681151 Benzoic acid, 4-[[(3,6-dioxo-1,4-cyclohexadienyl)methyl] amino]-, 1-adamantyl ester 0.0273093708703115 -0.15575382
NSC 683856 Null 0.0273093708703115 -0.13783654
NSC 685988 Dihydroartemisinyl ether, stereoisomer of NSC-685989 0.0273093708703115 0.19685764
NSC 686413 Null 0.0273093708703115 0.013304351
NSC 694493 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(3-pyridinyl)- 0.0273093708703115 0.15078244
NSC 724040 Null 0.0273093708703115 0.17761728
Total:52  Current:33    [First] [Prev] [Next] [Last]